Display options
Share it on

Open Forum Infect Dis. 2019 Jan 23;6(3):ofz029. doi: 10.1093/ofid/ofz029. eCollection 2019 Mar.

Bacteremic Community-Acquired Pneumonia in Ethiopian Children: Etiology, Antibiotic Resistance, Risk Factors, and Clinical Outcome.

Open forum infectious diseases

Abel Abera Negash, Daniel Asrat, Workeabeba Abebe, Tewodros Hailemariam, Tsegaye Hailu, Abraham Aseffa, Mario Vaneechoutte

Affiliations

  1. Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
  2. Laboratory Bacteriology Research, Department of Diagnostic Sciences, Faculty of Medicine & Health Sciences, Ghent University, Ghent, Belgium.
  3. Department of Microbiology and Immunology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
  4. Department of Pediatrics and Child Health, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
  5. Department of Pediatrics and Child Health, Yekatit 12 Medical College, Addis Ababa, Ethiopia.

PMID: 30838226 PMCID: PMC6396085 DOI: 10.1093/ofid/ofz029

Abstract

BACKGROUND: Community-acquired pneumonia (CAP) remains a leading cause of morbidity and mortality. We sought to determine the magnitude, etiology, and risk factors of CAP in children 5 years after introduction of pneumococcal conjugate vaccine (PCV) 10 in Ethiopia.

METHODS: We conducted a prospective observational study on the bacterial etiology and risk factors of CAP among children aged 0-15 years in 2 pediatric emergency departments in Addis Ababa, Ethiopia. Blood culture, antibiotic susceptibility testing, and amplification of pneumococcal

RESULTS: Out of 643 eligible children, 549 were enrolled. The prevalence of bacteremic pneumonia was 5.6%.

CONCLUSIONS: Five years after the introduction of PCV10 in Ethiopia,

Keywords: Ethiopia; PCV10; Staphylococcus aureus; Streptococcus pneumoniae; bacteremic community-acquired pneumonia

References

  1. Am J Trop Med Hyg. 2016 Feb;94(2):267-275 - PubMed
  2. Am J Clin Pathol. 1966 Apr;45(4):493-6 - PubMed
  3. Clin Infect Dis. 2012 Apr;54 Suppl 2:S190-9 - PubMed
  4. Am J Infect Control. 1988 Jun;16(3):128-40 - PubMed
  5. Am J Respir Crit Care Med. 2017 Jan 1;195(1):13-15 - PubMed
  6. Pediatrics. 2000 Nov;106(5):977-82 - PubMed
  7. Wien Klin Wochenschr. 2013 Nov;125(21-22):674-9 - PubMed
  8. J Glob Antimicrob Resist. 2014 Sep;2(3):148-154 - PubMed
  9. J Clin Microbiol. 2000 Oct;38(10):3870-1 - PubMed
  10. J Pediatr. 2016 Apr;171:111-5.e1-3 - PubMed
  11. Clin Infect Dis. 2012 Apr;54 Suppl 2:S146-52 - PubMed
  12. Int J Epidemiol. 2010 Apr;39 Suppl 1:i172-85 - PubMed
  13. PLoS One. 2015 Dec 22;10(12):e0145447 - PubMed
  14. Lancet Glob Health. 2019 Jan;7(1):e47-e57 - PubMed
  15. PLoS One. 2017 May 2;12(5):e0173314 - PubMed
  16. Pediatr Radiol. 2017 Oct;47(11):1392-1398 - PubMed
  17. Emerg Infect Dis. 2016 Jun;22(6): - PubMed
  18. Clin Infect Dis. 2014 May;58(10):1439-48 - PubMed
  19. J Clin Microbiol. 2003 Aug;41(8):3521-5 - PubMed
  20. Bull World Health Organ. 2005 May;83(5):353-9 - PubMed
  21. Pediatr Infect Dis J. 2004 Jul;23(7):642-9 - PubMed
  22. Lancet. 2005 Mar 26-Apr 1;365(9465):1139-46 - PubMed
  23. Lancet Glob Health. 2018 Jan;6(1):e74-e83 - PubMed
  24. Pneumonia (Nathan). 2017 May 25;9:8 - PubMed
  25. Bull World Health Organ. 2008 May;86(5):408-16 - PubMed
  26. Lancet. 2019 May 25;393(10186):2146-2154 - PubMed
  27. J Glob Health. 2015 Dec;5(2):050418 - PubMed

Publication Types